Schedule

DEA Policy Statement: Dispensing Controlled Substances for the Treatment of Pain
Description: 
This 2006 document explains the Drug Enforcement Agency's (DEA) role in regulation of controlled substances and the physician's legal responsibility to prescribe controlled substances for legitimate medical purposes.
Source: 
Drug Enforcement Agency (DEA)
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
TIP 40 Chapter 4: Treatment Protocols
Description: 
Discusses protocols for office-based buprenorphine treatment, including the administering of the drug itself, devising a treatment plan, and choosing an appropriate frequency for visits.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
4.5
Your rating: None Average: 4.5 (4 votes)
Tags:
Notification of Intent to Use Schedule III, IV, or V Opioid Drugs for Maintenance and Detoxification Treatment
Description: 
This form is for physicians to notify the DEA (through the Substance Abuse and Mental Health Services Administration) of their intent to use Schedule III, IV, or V drugs for treatment of opioid dependent patients.
Source: 
The National Alliance of Advocates for Buprenorphine Treatment (NAABT)
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Syndicate content